{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:08:48Z","timestamp":1788898128638,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93021C00029"],"award-info":[{"award-number":["75N93021C00029"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI125160"],"award-info":[{"award-number":["R01AI125160"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI181218"],"award-info":[{"award-number":["R01AI181218"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jim.2026.114114","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:58:25Z","timestamp":1788307105000},"page":"114114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a 96-well murine whole blood intracellular cytokine staining (ICS) assay for preclinical tuberculosis immune monitoring"],"prefix":"10.1016","volume":"551","author":[{"given":"Valerie A.","family":"Reese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey M.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha E.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Harne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2026.114114_bb0005","series-title":"Global Tuberculosis Report","author":"(WHO), W.H.O","year":"2025"},{"key":"10.1016\/j.jim.2026.114114_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by Bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.jim.2026.114114_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay0233","article-title":"Immune correlates of tuberculosis disease and risk translate across species","volume":"12","author":"Ahmed","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jim.2026.114114_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tube.2009.02.002","article-title":"Man and mouse TB: contradictions and solutions","volume":"89","author":"Apt","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jim.2026.114114_bb0025","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent tuberculosis: what are the sources of variability?","volume":"54","author":"Banaei","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2026.114114_bb0030","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S1472-9792(12)70009-4","article-title":"Rational approach to selection and clinical development of TB vaccine candidates","volume":"92","author":"Barker","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jim.2026.114114_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001094","article-title":"A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis","volume":"2","author":"Bertholet","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jim.2026.114114_bb0040","doi-asserted-by":"crossref","first-page":"36720","DOI":"10.1038\/srep36720","article-title":"IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection","volume":"6","author":"Booty","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jim.2026.114114_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2014.09.001","article-title":"Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-na\u00efve HIV-1-infected patients","volume":"414","author":"Bourguignon","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114114_bb0050","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fimmu.2019.00221","article-title":"Host transcriptomics as a tool to identify diagnostic and mechanistic immune signatures of tuberculosis","volume":"10","author":"Burel","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2021.102127","article-title":"Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease","volume":"131","author":"Burel","year":"2021","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.jim.2026.114114_bb0060","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijid.2017.01.030","article-title":"Experimental animal modelling for TB vaccine development","volume":"56","author":"Cardona","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jim.2026.114114_bb0065","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s40121-023-00806-0","article-title":"Safety and immunogenicity of the ID93 + GLA-SE tuberculosis vaccine in BCG-vaccinated healthy adults: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"12","author":"Choi","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.jim.2026.114114_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00226-21","article-title":"In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against Mycobacterium tuberculosis infection","volume":"12","author":"Clemmensen","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jim.2026.114114_bb0075","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/S1473-3099(21)00810-0","article-title":"Accelerating research and development of new vaccines against tuberculosis: a global roadmap","volume":"22","author":"Cobelens","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jim.2026.114114_bb0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of Bacillus Calmette-Gu\u00e9rin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.jim.2026.114114_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2026.114114_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"NPJ Vaccines."},{"key":"10.1016\/j.jim.2026.114114_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jim.2026.114114_bb0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3389\/fimmu.2019.00527","article-title":"Immunometabolic signatures predict risk of progression to active tuberculosis and disease outcome","volume":"10","author":"Duffy","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0110","article-title":"Inexpensive high-throughput multiplexed cytokine detection for tuberculosis diagnostics using amplified enzymatic metallization","volume":"XXX","author":"Elkhiyari","year":"2026","journal-title":"ACS Sens."},{"key":"10.1016\/j.jim.2026.114114_bb0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tube.2017.11.009","article-title":"Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention","volume":"109","author":"Fiore-Gartland","year":"2018","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.jim.2026.114114_bb0125","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.micinf.2005.10.033","article-title":"Lessons from experimental Mycobacterium tuberculosis infections","volume":"8","author":"Flynn","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jim.2026.114114_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010078","article-title":"Developing new anti-tuberculosis vaccines: focus on adjuvants","volume":"10","author":"Franco","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jim.2026.114114_bb0135","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1182\/blood-2006-05-021600","article-title":"IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo","volume":"109","author":"Fr\u00f6hlich","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jim.2026.114114_bb0140","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/S2666-5247(22)00303-2","article-title":"The role of bacterial vaccines in the fight against antimicrobial resistance: an analysis of the preclinical and clinical development pipeline","volume":"4","author":"Frost","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jim.2026.114114_bb0150","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4263079","article-title":"Animal models of tuberculosis vaccine research: an important component in the fight against tuberculosis","volume":"2020","author":"Gong","year":"2020","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jim.2026.114114_bb0155","series-title":"Vaccine Design: Methods and Protocols, Volume 1. Vaccines for Human Diseases","first-page":"387","article-title":"An update on tuberculosis vaccines","author":"Gopalaswamy","year":"2022"},{"key":"10.1016\/j.jim.2026.114114_bb0160","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jim.2004.06.010","article-title":"Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies","volume":"291","author":"Hanekom","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114114_bb0165","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2026.114114_bb0170","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jim.2014.12.003","article-title":"Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry","volume":"417","author":"Kagina","year":"2015","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114114_bb0175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3389\/fimmu.2017.01203","article-title":"TBVAC2020: advancing tuberculosis vaccines from discovery to clinical development","volume":"8","author":"Kaufmann","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0180","article-title":"Immunophenotyping and intracellular staining of fixed whole blood for mass cytometry (CyTOF)","volume":"101","author":"Kowli","year":"2020","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.jim.2026.114114_bb0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00281-015-0538-9","article-title":"Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies","volume":"38","author":"Kramnik","year":"2016","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jim.2026.114114_bb0190","article-title":"An RNA-based vaccine platform for use against Mycobacterium tuberculosis","volume":"11","author":"Larsen","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jim.2026.114114_bb0195","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41598-018-19523-7","article-title":"Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy","volume":"8","author":"Leem","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jim.2026.114114_bb0200","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ebiom.2017.12.004","article-title":"T cells primed by live mycobacteria versus a tuberculosis subunit vaccine exhibit distinct functional properties","volume":"27","author":"Lindenstrom","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jim.2026.114114_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005760","article-title":"A quantitative analysis of complexity of human pathogen-specific CD4 T cell responses in healthy M. tuberculosis infected South Africans","volume":"12","author":"Lindestam Arlehamn","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jim.2026.114114_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100029","article-title":"Analysis of myeloid cells in mouse tissues with flow cytometry","volume":"1","author":"Liu","year":"2020","journal-title":"STAR Protoc."},{"issue":"6","key":"10.1016\/j.jim.2026.114114_bb0220","doi-asserted-by":"crossref","first-page":"e841","DOI":"10.1016\/S2214-109X(21)00045-0","article-title":"Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study","volume":"9","author":"Mendelsohn","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jim.2026.114114_bb0225","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.4049\/jimmunol.135.5.3087","article-title":"Characterization of the requirements for human T cell mitogenesis by using suboptimal concentrations of phytohemagglutinin","volume":"135","author":"Mills","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112940","article-title":"Whole blood can be used as an alternative to isolated peripheral blood mononuclear cells to measure in vitro specific T-cell responses in human samples","volume":"492","author":"Moris","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2026.114114_bb0235","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/infdis\/jiy052","article-title":"Human immunodeficiency virus infection impairs Th1 and Th17 Mycobacterium tuberculosis\u2013Specific T-cell responses","volume":"217","author":"Murray","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jim.2026.114114_bb0240","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0320(20000501)40:1<60::AID-CYTO8>3.0.CO;2-J","article-title":"Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells","volume":"40","author":"Nomura","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.jim.2026.114114_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083884","article-title":"A dual TLR agonist adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93","volume":"9","author":"Orr","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2026.114114_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.tube.2020.102040","article-title":"The TB vaccine development pathway \u2013 an innovative approach to accelerating global TB vaccine development","volume":"126","author":"Roordink","year":"2021","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jim.2026.114114_bb0260","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/j.celrep.2017.03.007","article-title":"Th1 differentiation drives the accumulation of intravascular, non-protective CD4 T cells during tuberculosis","volume":"18","author":"Sallin","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jim.2026.114114_bb0265","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"Scriba","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100351","article-title":"Analysis of T cells in mouse lymphoid tissue and blood with flow cytometry","volume":"2","author":"Skordos","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.jim.2026.114114_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138042","article-title":"Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2026.114114_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138042","article-title":"Intracellular cytokine staining and flow cytometry: considerations for application in clinical trials of novel tuberculosis vaccines","volume":"10","author":"Smith","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2026.114114_bb0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.5588\/ijtld.21.0323","article-title":"The effect of new Mycobacterium tuberculosis infection on the sensitivity of prognostic TB signatures","volume":"25","author":"Sumner","year":"2021","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.jim.2026.114114_bb0290","series-title":"Signal Transduction Immunohistochemistry: Methods and Protocols","first-page":"155","article-title":"Flow cytometric analysis of cell Signaling proteins","author":"Suni","year":"2011"},{"key":"10.1016\/j.jim.2026.114114_bb0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/CDLI.7.2.155-160.2000","article-title":"Diagnosis of tuberculosis based on the two specific antigens Esat-6 and Cfp10","volume":"7","author":"van Pinxteren","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2026.114114_bb0300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.vaccine.2019.10.102","article-title":"A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults","volume":"38","author":"Wilkie","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2026.114114_bb0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/resp.13245","article-title":"Tuberculosis vaccines: opportunities and challenges","volume":"23","author":"Zhu","year":"2018","journal-title":"Respirology"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:55:15Z","timestamp":1788897315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175926000906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S0022175926000906"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2026.114114","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a 96-well murine whole blood intracellular cytokine staining (ICS) assay for preclinical tuberculosis immune monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2026.114114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114114"}}